IP Library Granted Patent US 8,426,191
Granted Patent B2
US 8,426,191 · App. 12/632,041 · Granted Apr 23, 2013

Materials and methods for efficient lactic acid production

Inventors: Shengde Zhou (Dekalb, IL); Lonnie O'Neal Ingram (Gainesville, FL); Keelnatham T. Shanmugam (Gainesville, FL); Lorraine Yomano (Gainesville, FL); Tammy B. Grabar (Gainesville, FL); Jonathan C. Moore (Gainesville, FL)
Assignee: University of Florida Research Foundation, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,426,191
App. No.
12/632,041
Granted
Apr 23, 2013
Kind
B2
Abstract

The present invention provides derivatives of Escherichia coli constructed for the production of lactic acid. The transformed E. coli of the invention are prepared by deleting the genes that encode competing pathways followed by a growth-based selection for mutants with improved performance. These transformed E. coli are useful for providing an increased supply of lactic acid for use in food and industrial applications.

Claims (14)

1. A genetically modified E. coli strain comprising the following modifications:

i) inactivation or deletion of an acetate kinase gene;

ii) inactivation or deletion of a fumarate reductase gene;

iii) inactivation or deletion of a pyruvate formatelyase gene;

iv) inactivation or deletion of an alcohol dehydrogenase gene;

v) inactivation or deletion of a methylglyoxal synthase gene; and

vi) insertion of a heterologous L-(+) lactate dehydrogenase (ldhL) gene.

2. The genetically modified E. coli stain according to claim 1 , wherein said heterologous L-(+) lactate dehydrogenase gene replaces the native ldhA gene encoding a D-(−) lactate dehydrogenase.

3. The genetically modified E. coli strain according to claim 1 , wherein said heterologous L-(+) lactate dehydrogenase gene is derived from Pediococcus Acidilactici.

4. The genetically modified E. coli strain according to claim 1 , wherein said E. coli strain is selected from a group consisting of TG105, TG106, TG107 and TG108.

5. A method of producing lactate or lactic acid comprising culturing the genetically modified E. coli strain according to claim 1 under conditions that allow for the production of lactic acid and optionally neutralizing the lactic acid to form lactate.

6. The method according to claim 5 , wherein said method produces L-(+)-lactate or L-(+)-lactic acid with a chiral purity of at least 99.9%.

7. The method according to claim 5 , wherein lactate or lactic acid is produced at concentrations of at least 0.5M.

8. A composition comprising culture medium and a genetically modified E. coli strain according to claim 1 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Feb 18, 2010
From: FLORIDA, UNIVERSITY OF
To: ENERGY, UNITED STATES DEPARTMENT OF
Reel/Frame 023954/0248 →
Continuity (5)
Continuation 11501137 · Aug 8, 2006
Provisional Application 60706887 · Aug 10, 2005
Provisional Application 60761576 · Jan 24, 2006
Provisional Application 60799619 · May 11, 2006
Related Publication 20100203602A1 · Aug 12, 2010